期刊
CELL REPORTS
卷 15, 期 2, 页码 274-287出版社
CELL PRESS
DOI: 10.1016/j.celrep.2016.03.037
关键词
-
类别
资金
- Belgian grants (Interuniversity Attraction Poles) [IAP 7/32]
- Flemish grants (Research Foundation Flanders) [FWO G.0875.11, FWO G.0973.11, FWO G.0A45.12N, FWO G.0787.13N, FWO G.0A54.13N, FWO G.0607.13N, FWO G0E04.16N]
- Methusalem grant [BOF09/01M00709, BOF16/MET_V/007]
- Ghent University grants (MRP, GROUP-ID consortium)
- Foundation against Cancer [F2012-188]
- VIB
- FWO postdoctoral grant
- FWO (Research Foundation Flanders)
- Methusalem grant
- FWO postdoctoral grants
Successful immunogenic apoptosis in experimental cancer therapy depends on the induction of strong host anti-tumor responses. Given that tumors are often resistant to apoptosis, it is important to identify alternative molecular mechanisms that elicit immunogenic cell death. We have developed a genetic model in which direct dimerization of FADD combined with inducible expression of RIPK3 promotes necroptosis. We report that necroptotic cancer cells release damage-associated molecular patterns and promote maturation of dendritic cells, the cross-priming of cytotoxic T cells, and the production of IFN-gamma in response to tumor antigen stimulation. Using both FADD-dependent and FADD-independent RIPK3 induction systems, we demonstrate the efficient vaccination potential of immunogenic necroptotic cells. Our study broadens the current concept of immunogenic cell death and opens doors for the development of new strategies in cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据